In Vitro hyperresponsiveness to tumor necrosis factor-α contributes to adipokine dysregulation in omental adipocytes of obese subjects

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1393-1400

  Maury, Eléonore ^a   Noël, Laurence ^a   Detry, Roger ^a   Brichard, Sonia M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADULT; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

SPRING VIREMIA OF CARP VIRUS;

EID: 65249085713     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2196     Document Type: Article

References (37)

1. Matsuzawa Y 2006 Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 3:35-42
2. Guerre-Millo M 2004 Adipose tissue and adipokines: for better or worse. Diabetes Metab 30:13-19
3. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lonn M 2006 Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 20:1540-1542
4. Skurk T, Alberti-Huber C, Herder C, Hauner H 2006 Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 92:1023-1033
5. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard SM 2007 Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293:E656-E665
6. Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM 1999 Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 84:4097-4105
7. Bobbioni-Harsch E, Bongard O, Habicht F, Weimer D, Bounameaux H, Huber O, Chassot G, Morel P, Assimacopoulos-Jeannet F, Golay A 2004 Relationship between sympathetic reactivity and body weight loss in morbidly obese subjects. Int J Obes Relat Metab Disord 28:906-911
8. Halleux CM, Servais I, Reul BA, Detry R, Brichard SM 1998 Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 83:902-910
9. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM 2001 Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288:1102-1107
10. Morange PE, Aubert J, Peiretti F, Lijnen HR, Vague P, Verdier M, Negrel R, Juhan-Vague I, Alessi MC 1999 Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue. Diabetes 48:890-895
11. Wang B, Trayhurn P 2006 Acute and prolonged effects of TNF-α on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch 452:418 -427
12. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867
13. Suganami T, Nishida J, Ogawa Y 2005 A paracrine loop between adipocytes andmacrophages aggravates inflammatorychanges: roleoffreefattyacidsand tumor necrosis factor α. Arterioscler Thromb Vasc Biol 25:2062-2068
14. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S, Kamei Y, Ogawa Y 2007 Role of the Toll-like receptor 4/NF-κB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 27:84-91
15. Tchernof A, Belanger C, Morisset AS, Richard C, Mailloux J, Laberge P, Dupont P 2006 Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes 55:1353-1360
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression oftumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409 -2415
17. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB 1995 The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
18. Fain JN, Bahouth SW, Madan AK 2004 TNFα release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord 28:616-622
19. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, Ranganathan G, Peterson CA, McGehee RE, Kern PA 2005 Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305-2313
20. p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46:451-455
21. Good M, Newell FM, Haupt LM, Whitehead JP, Hutley LJ, Prins JB 2006 TNF and TNF receptor expression and insulin sensitivity in human omental and subcutaneous adipose tissue-influence of BMI and adipose distribution. Diab Vasc Dis Res 3:26-33
22. Pandey M, Tuncman G, Hotamisligil GS, Samad F 2003 Divergent roles for p55 and p75 TNF-α receptors in the induction of plasminogen activator in hibitor-1. Am J Pathol 162:933-941
23. Liu LS, Spelleken M, Rohrig K, Hauner H, Eckel J 1998 Tumor necrosis factor-α acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor. Diabetes 47:515-522
24. Hube F, Hauner H 2000 The two tumor necrosis factor receptors mediate opposite effects on differentiation and glucose metabolism in human adipo- cytes in primary culture. Endocrinology 141:2582-2588
25. Cawthorn WP, Sethi JK 2008 TNF-α and adipocyte biology. FEBS Lett 582: 117-131
26. Lappas M, Yee K, Permezel M, Rice GE 2005 Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-κB and I kB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146:1491-1497
27. Vitseva OI, Tanriverdi K, Tchkonia TT, Kirkland JL, McDonnell ME, Apovian CM, Freedman J, Gokce N 2008 Inducible Toll-like receptor and NF-κB regulatory pathway expression in human adipose tissue. Obesity 16:932-937
28. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, Evans M, Harte AL, Kumar S 2007 Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292:E740-E747
29. Berg AH, Lin Y, Lisanti MP, Scherer PE 2004 Adipocyte differentiation induces dynamic changes in NF-κB expression and activity. Am J Physiol Endocrinol Metab 287:E1178 -E1188
30. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R 1996 Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 45:881-885
31. Paquot N, Castillo MJ, Lefebvre PJ, Scheen AJ 2000 No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients. JClin Endocrinol Metab 85:1316-1319
32. Dominguez H, Storgaard H, Rask-Madsen C, Steffen HT, Ihlemann N,Baunbjerg ND, Spohr C, Kober L, Vaag A, Torp-Pedersen C 2005 Metabolic and vascular effects of tumor necrosis factor-α blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res 42:517-525
33. Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK 2006 Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med 166:902-908
34. Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, Llorca J 2006 Anti-tumor necrosis factor-α blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:83-86
35. Kiortsis DN, Mavridis AK, Vasakos S, Nikas SN, Drosos AA 2005 Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis 64:765-766
36. Yazdani-Biuki B, Stelzl H, Brezinschek HP, Hermann J, Mueller T, Krippl P, Graninger W, Wascher TC 2004 Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-α antibody infliximab. Eur J Clin Invest 34:641-642
37. Prins JB, Niesler CU, Winterford CM, Bright NA, Siddle K, O'Rahilly S, Walker NI, Cameron DP 1997 Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes 46:1939-1944